SMTL ID : 5hpm.2 (1 other biounit)

Cetuximab Fab in complex with cyclic linked meditope

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.67 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain B: R.38, S.40, K.43, N.88 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:N.88 Hydrogen bonds: B:R.38, B:S.40, B:K.43, B:K.43 Water bridges: B:K.43

1 x CY3: 2-AMINO-3-MERCAPTO-PROPIONAMIDE(Covalent)

CY3.2: 4 residues within 4Å: Chain A: I.10, K.103 Chain C: X.1, K.11 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:L.10

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-06-15

Peptides

Cetuximab Fab light chain: A
Cetuximab Fab heavy chain: B
Cyclic amidated, acetylated linked meditope: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
F

Cetuximab Fab light chain

Cetuximab Fab heavy chain

Cyclic amidated, acetylated linked meditope

Related Entries With Identical Sequence